ARCHIVES

Administration Asking $233 Million Less For NCI In FY ’88 Than Congress Is Appropriating For ‘87

This article is from The Cancer Letter archive.

Vol. 12 No. 39 | October 10, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI

January 7, 1977

Congressional Committees Add Provisions To Cancer Act Renewal Bills To Strengthen NCI’s Independence, Prevent Fund Withholding

March 8, 1974

In Brief: Bishop No Longer Candidate For NCI Director; HHS Endorses Intramural Scientist Klausner

April 21, 1995

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002